Skip to main content

Steris Corp(STE-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low212.17
Day High221.34
Open:220.34
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Steris Corp

Select a category then submit the form to load news
StockStory
3 Healthcare Stocks We Think Twice About
STE
StockStory
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
TECH
StockStory
The 5 Most Interesting Analyst Questions From STERIS’s Q4 Earnings Call
STE
Tipranks
Steris Earnings Call: Growth Holds, Tariffs Bite
Tipranks
Steris Insider 10b5-1 Stock Sale Plan Raises Governance and Sentiment Questions
Tipranks
Analysts Offer Insights on Healthcare Companies: Steris (STE) and Roche Holding AG (OtherRHHVF)
Stock Target Advisor
Stocks Continue to Struggle: Market Analysis for Feb 5th, 2026
Stocks Continue to Struggle: Market Analysis for Feb 5th, 2026
Motley Fool
STERIS (STE) Q3 2026 Earnings Call Transcript
StockStory
STERIS (NYSE:STE) Beats Q4 CY2025 Sales Expectations
STE
GlobeNewswire
STERIS Announces Financial Results for Fiscal 2026 Third Quarter
Zacks Investment Research
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
Zacks Investment Research
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test
Zacks Investment Research
MedTech Stocks to Watch for Earnings on Feb. 4: BSX, ALGN & More
MedTech Stocks to Watch for Earnings on Feb. 4: BSX, ALGN & More
StockStory
What To Expect From STERIS’s (STE) Q4 Earnings
STE
Tipranks
Analysts Offer Insights on Healthcare Companies: Steris (STE), Arcellx Inc (ACLX) and BioCryst (BCRX)
GlobeNewswire
STERIS Announces Dividend of $0.63 per share
Zacks Investment Research
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
Zacks Investment Research
BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry
BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX) and Steris (STE)
StockStory
1 Profitable Stock with Exciting Potential and 2 Facing Challenges
VZ
Zacks Investment Research
ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines
ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines
StockStory
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky
AIN
GlobeNewswire
STERIS to Host a Conference Call for Fiscal 2026 Third Quarter Results on February 5, 2026
Zacks Investment Research
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Zacks Investment Research
SNN Boosts Shoulder Repair Portfolio With Integrity Orthopaedics Deal
SNN Boosts Shoulder Repair Portfolio With Integrity Orthopaedics Deal
Tipranks
Maybank Keeps Their Hold Rating on Steris (STE)
StockStory
1 Mid-Cap Stock for Long-Term Investors and 2 Facing Challenges
IOT
StockStory
Surgical Equipment & Consumables - Diversified Stocks Q3 Earnings: STERIS (NYSE:STE) Best of the Bunch
STE
Zacks Investment Research
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety
Zacks Investment Research
Illumina's New Connected Multiomics Platform Set to Boost Its Stock
Illumina's New Connected Multiomics Platform Set to Boost Its Stock
StockStory
3 Hyped Up Stocks We Steer Clear Of
TWLO
StockStory
3 Low-Volatility Stocks That Concern Us
DPZ

Profile

STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.